The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians · 2011
Pregnancy outcomes in women with elevated levels of fetal hemoglobin.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Murji Ally, Sobel Mara L, Hasan Lara, McLeod Anne, Waye John S, Sermer Mathew, Berger Howard
Аннотация
OBJECTIVE: Elevated maternal levels of fetal hemoglobin (HbF) present a unique situation where both mother and fetus produce hemoglobin with equivalent oxygen affinities. We aimed to determine pregnancy outcomes in women with persistently elevated HbF.
METHODS: In this retrospective cohort study, women with HbF levels exceeding 10% were identified by searching a provincial database. Maternal, obstetric, and neonatal outcomes were extracted from chart reviews performed at two hospitals.
RESULTS: Twenty-two women with a total of 43 pregnancies and 33 live births were identified. Maternal levels of HbF ranged between 11 and 100%. Women with HbF ≥ 70% were significantly more likely to deliver growth-restricted or small for gestational age (SGA) fetuses compared to the group of women with HbF < 70% (100% versus 8%; p < 0.01). Three women (4/32 pregnancies) received blood transfusions, which was unrelated to HbF levels.
CONCLUSIONS: Pregnancies complicated by maternal HbF levels ≥ 70% are at increased risk of intra-uterine growth restriction or SGA fetuses. Increased antenatal surveillance is suggested.
METHODS: In this retrospective cohort study, women with HbF levels exceeding 10% were identified by searching a provincial database. Maternal, obstetric, and neonatal outcomes were extracted from chart reviews performed at two hospitals.
RESULTS: Twenty-two women with a total of 43 pregnancies and 33 live births were identified. Maternal levels of HbF ranged between 11 and 100%. Women with HbF ≥ 70% were significantly more likely to deliver growth-restricted or small for gestational age (SGA) fetuses compared to the group of women with HbF < 70% (100% versus 8%; p < 0.01). Three women (4/32 pregnancies) received blood transfusions, which was unrelated to HbF levels.
CONCLUSIONS: Pregnancies complicated by maternal HbF levels ≥ 70% are at increased risk of intra-uterine growth restriction or SGA fetuses. Increased antenatal surveillance is suggested.